MLPMX
Price
$5.86
Change
+$0.10 (+1.74%)
Updated
Jun 2 closing price
Net Assets
331.2M
MLPNX
Price
$7.79
Change
+$0.12 (+1.56%)
Updated
Jun 2 closing price
Net Assets
331.2M
Interact to see
Advertisement

MLPMX vs MLPNX

Header iconMLPMX vs MLPNX Comparison
Open Charts MLPMX vs MLPNXBanner chart's image
MLPMX vs MLPNX Comparison Chart in %
View a ticker or compare two or three
VS
MLPMX vs. MLPNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPMX is a Buy and MLPNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPMX (331M) and MLPNX (331M) have equal amount of cash in the bank . MLPMX pays higher dividends than MLPNX: MLPMX (6.22) vs MLPNX (4.67). MLPMX was incepted earlier than MLPNX: MLPMX (14 years) vs MLPNX (14 years). MLPMX (4.49) is less costly to investors than MLPNX (3.49). MLPMX (25.00) and MLPNX (25.00) have comparable annual turnover. MLPMX (1000) and MLPNX (1000) have matching initial minimum investment requirements. MLPNX (27.60) and MLPMX (26.32) have marching annual gain over last year. MLPNX return over 5 years is better than : 228.23 vs. MLPMX (211.61).
MLPMXMLPNXMLPMX / MLPNX
Total Expense Ratio4.493.49129%
Annual Report Gross Expense Ratio4.493.49129%
Fund Existence14 years14 years-
Gain YTD22.85623.53797%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets331M331M100%
Annual Yield % from dividends6.224.67133%
Returns for 1 year26.3227.6095%
Returns for 3 years119.35126.0195%
Returns for 5 years211.61228.2393%
Returns for 10 years127.28151.4484%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMG310.528.07
+2.67%
Affiliated Managers Group
EPAC33.160.23
+0.70%
Enerpac Tool Group Corp
HBANP16.50-0.10
-0.60%
Huntington Bancshares
MKTW17.14-0.12
-0.67%
MarketWise Inc
AVIR4.28-0.11
-2.40%
Atea Pharmaceuticals